Riyan Zhang - Panion BF Independent Director

All Insiders . Taiwan . 
Stock . Panion BF Biotech . Stakeholders . Insider . Riyan Zhang
1760 Stock  TWD 89.60  0.10  0.11%   

Insider

Riyan Zhang is Independent Director of Panion BF Biotech since 2014.
Tenure 10 years
Phone886 2 2655 8218
Webhttps://www.pbf.com.tw

Panion BF Management Efficiency

The company has return on total asset (ROA) of 0.0805 % which means that it generated a profit of $0.0805 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1355 %, meaning that it generated $0.1355 on every $100 dollars invested by stockholders. Panion BF's management efficiency ratios could be used to measure how well Panion BF manages its routine affairs as well as how well it operates its assets and liabilities.
Panion BF Biotech has accumulated 116.07 M in total debt with debt to equity ratio (D/E) of 0.93, which is about average as compared to similar companies. Panion BF Biotech has a current ratio of 1.47, which is within standard range for the sector. Debt can assist Panion BF until it has trouble settling it off, either with new capital or with free cash flow. So, Panion BF's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Panion BF Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Panion to invest in growth at high rates of return. When we think about Panion BF's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

ChungCheng LiuAdimmune Corp
N/A
ChihHsiang LengAdimmune Corp
N/A
ChinChuan ChangAdimmune Corp
N/A
Sharon LeeOBI Pharma
N/A
ChengEn TsaiOBI Pharma
N/A
Kevin PoulosOBI Pharma
64
YuNan ShihOBI Pharma
N/A
MingTien LaiOBI Pharma
N/A
LiYa TangAdimmune Corp
N/A
Colin KaoOBI Pharma
N/A
Yun YanOBI Pharma
N/A
ChiHsien ChanAdimmune Corp
N/A
Mitchell MSOBI Pharma
N/A
YinTeng ChangAdimmune Corp
N/A
Wayne MDOBI Pharma
N/A
Victoria LinOBI Pharma
N/A
ChiChuan ChenOBI Pharma
65
MBA MDAdimmune Corp
N/A
PoJen ChangOBI Pharma
N/A
FACP FACPOBI Pharma
67
Panion Bf Biotech Inc., a biotechnology pharmaceutical company, manufactures and sells various pharmaceutical products in Taiwan. Panion Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei City, Taiwan. PANION BF operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange. Panion BF Biotech (1760) is traded on Taiwan Stock Exchange in Taiwan and employs 16 people.

Management Performance

Return On Equity0.14
Return On Asset0.0805

Panion BF Biotech Leadership Team

Elected by the shareholders, the Panion BF's board of directors comprises two types of representatives: Panion BF inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Panion. The board's role is to monitor Panion BF's management team and ensure that shareholders' interests are well served. Panion BF's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Panion BF's outside directors are responsible for providing unbiased perspectives on the board's policies.
WengFoung Huang, Director
Fengren Wang, Deputy General Manager
Riyan Zhang, Independent Director
Jizhou Liao, Independent Director
Chongqi Cai, Director
Zhiming Lin, Director
ChungChi Tsai, VP
Defu Xie, Director
Li Chang, Chairman of the Board
Chung Chiang, General Manager, Director
Junping Lu, Deputy General Manager
Jinxuan Chen, Independent Director
Qingsui Yi, Director
Junda Zheng, Director
Wenting Ke, Deputy General Manager

Panion Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Panion BF a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.14
Return On Asset0.0805
Profit Margin0.11 %
Operating Margin0.17 %
Current Valuation15.29 B
Shares Outstanding85.74 M
Shares Owned By Insiders33.64 %
Shares Owned By Institutions0.68 %
Price To Book7.27 X
Price To Sales6.42 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America

Additional Tools for Panion Stock Analysis

When running Panion BF's price analysis, check to measure Panion BF's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Panion BF is operating at the current time. Most of Panion BF's value examination focuses on studying past and present price action to predict the probability of Panion BF's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Panion BF's price. Additionally, you may evaluate how the addition of Panion BF to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY